Asset
BX004-A
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05010577 | phase1_2 | completed | 2022-06-21 | 2024-03-10 | BiomX, Inc. | Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection |
| NCT06998043 | phase2 | recruiting | 2025-07-02 | 2026-03-01 | BiomX Ltd | Study With Phage for CF Subjects With Pseudomonas Lung Infection |
FDA applications (0)
This company has no applications containing this asset.